多靶点重复经颅磁刺激治疗帕金森病运动与情绪症状:随机试验
这项多中心、双盲、假对照试验纳入伴抑郁的帕金森病患者,随机分为双侧M1、DLPFC、M1+DLPFC或双假刺激组,接受10次rTMS。主要终点为1个月时UPDRS-III和HDRS变化。结果显示M1 rTMS改善运动功能优于假刺激,而DLPFC rTMS对抑郁的改善不优于假刺激,联合刺激无协同效应。
要点
- M1高频rTMS可改善伴抑郁帕金森病患者的运动症状。
- DLPFC rTMS治疗2周对抑郁的改善不优于假刺激。
- 同时刺激M1和DLPFC未显示协同效应。
核心结论
- 在伴抑郁的帕金森病患者中,M1 rTMS是改善运动症状的有效治疗,而DLPFC rTMS对情绪的获益不优于假刺激。
- 每个rTMS session同时靶向M1和DLPFC未显示协同效应。
研究设计与样本
- 多中心、双盲、假对照、平行组研究,比较真实与逼真(电)假rTMS。
- 计划招募160例,筛查85例,随机61例,完成所有访视50例。
- 患者随机分为4组:双侧M1(+假DLPFC)、DLPFC(+假M1)、M1+DLPFC、双假刺激。
- TMS疗程为10次每日session,左侧DLPFC 2000个刺激,每侧M1 1000个刺激(50×4秒串,每串40个刺激,10 Hz)。
- 主要终点为1个月时UPDRS-III运动功能和HDRS抑郁变化。
主要发现
- 真实M1 rTMS在主要终点时运动功能改善优于假刺激(p < 0.05)。
- DLPFC组与双假组相比,情绪无改善。
- 联合M1和DLPFC刺激对运动或情绪症状均无额外获益。
关键数值与推荐
- M1 rTMS改善运动功能优于假刺激,p < 0.05。
- DLPFC rTMS对抑郁的改善不优于假刺激。
- 联合刺激无协同效应。
临床怎么用
- 对于伴抑郁的帕金森病患者,可考虑M1高频rTMS改善运动症状。
- 不推荐仅用DLPFC rTMS治疗抑郁,因2周疗程未优于假刺激。
- 不建议常规联合M1和DLPFC刺激,因无协同证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether multifocal, high-frequency repetitive transcranial magnetic stimulation (rTMS) of motor and prefrontal cortex benefits motor and mood symptoms in patients with Parkinson disease (PD). METHODS: Patients with PD and depression were enrolled in this multicenter, double-blind, sham-controlled, parallel-group study of real or realistic (electric) sham rTMS. Patients were randomized to 1 of 4 groups: bilateral M1 ( + sham dorsolateral prefrontal cortex [DLPFC]), DLPFC ( + sham M1), M1 + DLPFC, or double sham. The TMS course consisted of 10 daily sessions of 2,000 stimuli for the left DLPFC and 1,000 stimuli for each M1 (50 × 4-second trains of 40 stimuli at 10 Hz). Patients were evaluated at baseline, at 1 week, and at 1, 3, and 6 months after treatment. Primary endpoints were changes in motor function assessed with the Unified Parkinson's Disease Rating Scale-III and in mood with the Hamilton Depression Rating Scale at 1 month. RESULTS: Of the 160 patients planned for recruitment, 85 were screened, 61 were randomized, and 50 completed all study visits. Real M1 rTMS resulted in greater improvement in motor function than sham at the primary endpoint (p < 0.05). There was no improvement in mood in the DLPFC group compared to the double-sham group, as well as no benefit to combining M1 and DLPFC stimulation for either motor or mood symptoms. CONCLUSIONS: In patients with PD with depression, M1 rTMS is an effective treatment of motor symptoms, while mood benefit after 2 weeks of DLPFC rTMS is not better than sham. Targeting both M1 and DLPFC in each rTMS session showed no evidence of synergistic effects. CLINICALTRIALSGOV IDENTIFIER: NCT01080794. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that in patients with PD with depression, M1 rTMS leads to improvement in motor function while DLPFC rTMS does not lead to improvement in depression compared to sham rTMS.
引用
- Brys M, Fox MD, Agarwal S, et al. Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial. Neurology. 2016. PMID: 27708129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。